CompletedNot Applicable

Silent Threat: Impact of Preoperative Albumin Levels on Outcomes in Geriatric Cancer Surgery

Turkey (Türkiye)330 participantsStarted 2025-04-01

Plain-language summary

This retrospective, single-center study aims to evaluate the impact of preoperative albumin levels on postoperative outcomes in geriatric patients (aged 65 and above) undergoing cancer surgery. The study will compare postoperative complication rates, length of hospital stay, and intensive care needs between patients with hypoalbuminemia and those with normal albumin levels.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 65 years or older * Diagnosed with cancer and underwent cancer surgery * Preoperative albumin level recorded before surgery Exclusion Criteria: * Preoperative sepsis, severe infection, or active inflammatory disease * Emergency or palliative surgery * Missing preoperative albumin value * Incomplete medical records or follow-up data

What they're measuring

Postoperative Complication Rate

Timeframe: within 30 days after surgery

Trial details

NCT IDNCT06998030

SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Neoplasms trials